On June 21st and 22nd, the Biodonostia HRI hosted the meeting to launch the European project “Data-Driven Drug Discovery for Wound Healing (4D-HEALING)”, coordinated by Dr. Marcos J. Araúzo-Bravo, leader of the Institute’s Computational Biology and Systems Biomedicine Group, in which Dr. Ander Izeta from the Tissue Engineering Group also participates as Project Manager.

Over the next three years, the project will analyse the cicatrisation of human wounds using the innovative technology of single-cell transcriptome analyses, with the aim of using computational methods to identify molecular targets and drugs currently on the market that can be repositioned to improve cutaneous wound healing.

The project has been funded with 1.4M euros in the H2020 second call for projects, “ERACoSysMed – Systems Medicine to address clinical needs”, seeking to promote the implementation of approximations based on systems biology in clinical research and medical practice. Systems medicine will provide a new tool to researchers and doctors, enabling the latter to diagnose and treat patients faster and more effectively, and has the potential of being able to advance towards the production of personalised medicines.

Participants in the project besides the Biodonostia HRI are Monasterium Laboratory Skin & Hair Research Solutions GmbH (Germany), University of Ljubljana, Faculty of Medicine, Medical Center for Molecular Biology (Slovenia), Mathematical Institute, Slovak Academy of Sciences, Bratislava (Slovakia), Medical University of Vienna, Department of Molecular Neurosciences (Austria), DEBRA Austria (Austria ), Plastic and Reconstructive Surgery Research, University of Manchester (UK), European Bioinformatics Institute (EMBL-EBI) and WT Sanger Institute, Cambridge (UK).